Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InBody CoXKRX:041830 -3.60%86 Median PS Value is ₩47,080.84 as of Sep. 03, 2026. GuruFocus rates XKRX:041830 with a GF Score™ of 86/100 and a GF Value™ of ₩35,473.99 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 340 Medical Devices & Instruments companies, InBody Co ranks worse than 85.29% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. InBody Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₩20205.502. InBody Co's 10-Year median PS Ratio is 2.3301. Therefore, the Median PS Value for today is ₩47,080.84.
As of today (2026-09-03), InBody Co's share price is ₩58900.00. InBody Co's Median PS Value is ₩47,080.84. Therefore, InBody Co's Price to Median PS Value for today is 1.25.
The historical rank and industry rank for InBody Co's Median PS Value or its related term are showing as below:
XKRX:041830'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.47 Med: 0.66 Max: 1.97
Current: 1.25
During the past 13 years, the highest Price to Median PS Value of InBody Co was 1.97. The lowest was 0.47. And the median was 0.66.
XKRX:041830's Price-to-Median-PS-Value is ranked worse than 85.29% of 340
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs XKRX:041830: 1.25
InBody Co (XKRX:041830) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
InBody Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
58900.00
/
47,080.84
=
1.25
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InBody Co Median PS Value Related Terms
InBody Co Median PS Value Historical Data
* Premium members only.
The historical data trend for InBody Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:041830 vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, InBody Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InBody Co Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InBody Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where InBody Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.3301.
InBody Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩20205.502.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InBody Co (XKRX:041830) has a Median PS Value of ₩47,080.84 as of Sep. 03, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on InBody Co and its competitors. According to the industry distribution chart, InBody Co ranks #290 out of 340 companies in the Medical Devices & Instruments industry, placing it in the top 85.3%.
Is InBody Co's Median PS Value too high?
InBody Co's current Median PS Value is ₩47,080.84. Based on the distribution chart, InBody Co ranks #290 out of 340 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, InBody Co has a GF Score™ of 86/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InBody Co's Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, InBody Co ranks #290 out of 340 companies for Median PS Value. This places InBody Co in the lower half of its industry. The industry median Median PS Value is 0.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 340 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on InBody Co and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InBody Co's current Median PS Value is ₩47,080.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InBody Co stock overvalued right now?
Based on GuruFocus' analysis, InBody Co (XKRX:041830) is currently considered Significantly Overvalued. The stock's GF Value™ is ₩35,473.99, compared to a current price of ₩58,900.00 — trading 66% above its estimated fair value. The current Median PS Value is ₩47,080.84. InBody Co's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For InBody Co (XKRX:041830), the current Median PS Value is ₩47,080.84 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InBody Co (XKRX:041830) Overvalued in 2026?
Based on GuruFocus' analysis, InBody Co stock appears to be overvalued.
The current stock price of ₩58,900.00 is trading 66% above its estimated GF Value™ of ₩35,473.99.
GuruFocus considers InBody Co to be Significantly Overvalued.
Key valuation signals for XKRX:041830:
Median PS Value: ₩47,080.84
GF Value™: ₩35,473.99 vs. price of ₩58,900.00 (66% above fair value)
No single metric tells the full story. See the XKRX:041830 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.
86GF Score
Get the complete analysis for XKRX:041830
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:041830 has been successfully added to your 
